J Endocrinol Metab

Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access

Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc

Journal website https://www.jofem.org

Original Article

Volume 14, Number 4, August 2024, pages 194-206

Evaluation of Nine Forms of Metabolic Syndrome Diagnosis as Risk for Cardiovascular Disease: An Analysis of Isolated and Combined Metabolic Factors

Figures

Figure 1. Prevalence of each definition of MetS. MetS: metabolic syndrome; ATPIII: Adult Treatment Panel III; IDF: International Diabetes Federation; WHO: World Health Organization; JIS: Joint Interim Statement; EGIR: European Group for the Study of Insulin Resistance; AHA: American Heart Association; AACE: American Association of Clinical Endocrinologists; ALAD: Latin American Diabetes Association; ILIBLA: International Lipid Information Bureau Latin America.

Figure 2. Forest plot regression analysis of each definition of MetS as risk of cardiovascular disease. MetS: metabolic syndrome; ATPIII: Adult Treatment Panel III; IDF: International Diabetes Federation; WHO: World Health Organization; JIS: Joint Interim Statement; EGIR: European Group for the Study of Insulin Resistance; AHA/NHLBI: American Heart Association and National Heart, Lung, and Blood Institute; AACE: American Association of Clinical Endocrinologists; ALAD: Latin American Diabetes Association; ILIBLA: International Lipid Information Bureau Latin America.

Figure 3. Different combinations of each MetS definition as CVD risk. For individual data the indicators were: low HDL, HyperTg = hypertriglyceridemia, hyperglycemia, HBP= high blood pressure and abdominal obesity. For the data as a whole: W = altered waist circumference, G = hyperglycemia, T = hypertriglyceridemia, H = low HDL, B = elevated blood pressure, D = T2DM/hyperglycemia, O = obesity, T = triglycerides, DO = diabetes and obesity. MetS: metabolic syndrome; CVD: cardiovascular diseases; T2DM: type 2 diabetes mellitus; HDL: high-density lipoprotein.

Table

**Table 1.** Demographic Characteristics of Participants
Characteristic	Results (n = 946)
MetS: metabolic syndrome.
Sex, n (%)
Female	506 (53.49%)
Male	440 (46.51%)
Age group, n (%)
29 - 44 years	423 (44.71%)
45 - 59 years	397 (41.97%)
60 years to more	126 (13.32%)
Group, n (%)
Rural	183 (19.34%)
Migrant	573 (60.57%)
Urban	190 (20.08%)
Wealth index, n (%)
Lowest	320 (33.83%)
Middle	318 (33.62%)
Highest	308 (32.56%)
Educational level, n (%)
None/some primary	305 (32.31%)
Primary complete	142 (15.04%)
Secondary to more	497 (52.65%)
Physical activity, n (%)
Low	244 (26.01%)
Moderate	274 (29.21%)
High	420 (44.78%)
Current smoker, n (%)
No	842 (89.01%)
Yes	104 (10.99%)
Alcohol volume, n (%)
Low	862 (91.12%)
High	84 (8.88%)
Body mass index, n (%)
Normal weight	384 (40.59%)
Overweight	370 (39.11%)
Obesity	192 (20.30%)
Mets global, n (%)
No	562 (59.41%)
Yes	384 (40.59%)
Cardiovascular disease, n (%)
No	930 (98.31%)
Yes	16 (1.69%)